Page last updated: 2024-10-24

cefixime and Hemolysis

cefixime has been researched along with Hemolysis in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imran, M1
Shah, MR1
Ullah, F1
Ullah, S1
Sadiq, A1
Ali, I1
Ahmed, F1
Nawaz, W1

Other Studies

1 other study available for cefixime and Hemolysis

ArticleYear
Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime.
    Artificial cells, nanomedicine, and biotechnology, 2017, Volume: 45, Issue:7

    Topics: Animals; Biological Availability; Cefixime; Drug Carriers; Drug Liberation; Female; Glycosides; Hemo

2017